Asian American and Pacific Islander patients with melanoma have increased odds of treatment delays: A cross-sectional study

Asian American and Pacific Islander (AAPI) melanoma patients have higher mortality than non-Hispanic White (NHW) patients. Treatment delays may contribute, but whether AAPI patients have longer time from diagnosis to definitive surgery (TTDS) is unknown. Investigate TTDS differences between AAPI and...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Academy of Dermatology 2023-09, Vol.89 (3), p.529-536
Main Authors: Fane, Lauren S., Wei, Angela H., Tripathi, Raghav, Bordeaux, Jeremy S.
Format: Article
Language:English
Subjects:
Asian
chemotherapy
disparities
immunotherapy
insurance
melanoma
mortality
National Cancer Database
non-Hispanic White
racial
stage
survival
time to definitive surgery
time to treatment
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Asian American and Pacific Islander (AAPI) melanoma patients have higher mortality than non-Hispanic White (NHW) patients. Treatment delays may contribute, but whether AAPI patients have longer time from diagnosis to definitive surgery (TTDS) is unknown. Investigate TTDS differences between AAPI and NHW melanoma patients. Retrospective review of AAPI and NHW melanoma patients in the National Cancer Database (NCD) (2004-2020). The association of race with TTDS was evaluated by multivariable logistic regression, controlling for sociodemographic characteristics. Of 354,943 AAPI and NHW melanoma patients identified, 1155 (0.33%) were AAPI. AAPI patients had longer TTDS for stage I, II, and III melanoma (P 90 days. Racial differences in TTDS persisted in Medicare and private insurance types. Uninsured AAPI patients had the longest TTDS (mean, 53.26 days), while those with private insurance had the shortest TTDS (mean, 34.92 days; P 
ISSN:0190-9622
1097-6787
DOI:10.1016/j.jaad.2023.05.028